New York, Global Insight Services have recently published a report on Overactive Bladder (OAB) – Drug Pipeline Landscape, 2022. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Overactive bladder (OAB) is a condition in which the bladder muscle contracts too often and causes urinary frequency, urgency, and incontinence. It affects both men and women, but is more common in women.
The causes of overactive bladder include neurological disorders, such as stroke, multiple sclerosis and eak pelvic muscles, diabetes, urinary tract infections, excess consumption of caffeine or alcohol, declining cognitive function due to aging, difficulty walking.
The most common symptoms of overactive bladder include urinary urgency, frequency of urination, urge incontinence and nocturia.
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31024
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Some of the key players involved in development of Overactive Bladder (OAB) therapeutics are :
Key Players
• Aardvark Therapeutics Inc
• Astellas Pharma Inc
• Bayer
• DelNova
• Dong-A ST Co., Ltd.
• DongKoo Bio & Pharma Co Ltd
• Exxel Pharma Inc
• Hugel
• Imbrium Therapeutics
• Jeil Pharmaceutical Co., Ltd.
• Korea United Pharm Inc
• Pantherics Inc
• PeLeMed Co Ltd
• Sea4Us
• Taiho Pharmaceutical Co., Ltd.
• Urovant Sciences GmbH
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31024
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700